definiens: means all information, know - how and/or expertise in relation to theresearch, development or use of hw'\l90I - DM I in the Field, whether alone or in combination withanother product or pharmaceutical agent, ( excluding Manufacturing Information ) including, without limiting the generality of the foregoing, ( I ) results of Pre - Clinical Studies and ClinicalStudies, ( 2 ) discoveries, practices, methods, knowledge, processes, ideas, skill, experience, know - how, technology, trade secrets, purification and isolation techniques, instructions, formulae, data, assays, drawings and designs, ( 3 ) chemical, pharmacoeeonomic, toxicological, pharmacological, analytical, safety, quality control and testing data, and ( 4 ) all applications, registrations, licenses, authorizations, approvals and correspondence submitted to or received from, any regulatoryauthorities in the ' Territory relating to huN90l - DMI ( including, without limitation, minutes andmeeting notes relating to any communications with any regulatory authority in the Territoryrelating to huN90I - DMI ) in the possession and at the free disposal of [COMPANY], BB or Sub - licensees,1.48 means:1.48.1 all countries for the time being of the European Union ( ) and the EuropeanEconomic Area ( ) as constituted at the Effective Date . For the avoidance of doubt, new member countries of the EU and/or the EEA will automatically be included in thedefmition of Territory provided that [COMPANY] has not otherwise licensed the Licensed1P to another party in that country hetween the Effective Date and the date the countryjoins either the EU or the EEA ; and1.48.2 Japan